Anticoagulation Stewardship: Optimizing Treatment for Venous Thromboembolism Across the Continuum of Care

Anticoagulation Stewardship: Optimizing Treatment for Venous Thromboembolism Across the Continuum of Care

September 22, 2022
2:00 pm

Bringing Science Into Practice Public Health Webinar Series on Blood Disorders

The CDC Division of Blood Disorders is proud to offer this webinar series, providing evidence-based information on new research, emerging issues of interest in blood disorders, as well as innovative approaches to collaboration.

Please Preregister Here

The estimated number of patients requiring anticoagulation therapy for treatment of venous thromboembolism (VTE) is anticipated to double by 2050. Anticoagulants, which are essential for treatment and prevention of VTE, have persisted as the leading class of medications associated with emergency department visits for adverse medication events for more than a decade. The advent of direct oral anticoagulants (DOACs) has been shown to be safer than alternative agents, such as warfarin, in clinical trials but not in real-world practice. Frequent inappropriate dosing and prescribing have been documented in numerous studies. Enhanced efforts around the improved use of anticoagulants for VTE and other thromboembolic disease states are imperative to change the current unfavorable trajectory of patient harm due to these high-risk, yet essential, therapies. In this webinar, Dr. Burnett will define anticoagulation stewardship and describe practice-level initiatives and national-level momentum behind these types of programs. She will also discuss the role of pharmacists within the multidisciplinary team to promote anticoagulation stewardship for VTE patients throughout the continuum of care. Finally, she will summarize relevant clinical resources to aid clinicians in optimizing the care of VTE patients.

Learning Objectives:

1. Describe anticoagulation stewardship and why there is an urgent need for
such focused clinical initiatives around VTE.
2. Describe the role of pharmacists within the multidisciplinary team to
translate evidence into clinical practice for patients with VTE.
3. Describe current resources and educational opportunities to aid clinicians
in improved care of VTE patients.


Allison E. Burnett, PharmD, PHC, CACP

President, Anticoagulation Forum, Antithrombosis Stewardship Pharmacist, University of New Mexico Hospital, Associate Adjunct Clinical Professor, University of New Mexico College of Pharmacy


Caroline Cromwell, MD

NBCA MASAB Member, Assistant Professor of Medicine, Icahn School of Medicine at Mount Sinai; Medical Director, Thrombosis Services Program, Mount Sinai Health System

This webinar is free and open to public health professionals, clinicians, and researchers who desire more information about venous thromboembolism. Advance registration is required, and the number of attendees is limited.

Please Preregister Here

For more information please contact Cynthia Sayers: cay1@cdc.gov

Download this Flyer

Current News

The National Blood Clot Alliance Launches New Council for Emerging Researchers in Thrombosis (CERT)

FOR IMMEDIATE RELEASE: 07/28/2022   The National Blood Clot Alliance (NBCA), the nation’s leading nonprofit patient advocacy organization dedicated to…

The FUVID Study

The FUVID Study (Functional Characterization of Chronic Thromboembolic Venous Disease in Children) is currently open for enrollment to qualified participants.…